GILD:NGS-Gilead Sciences Inc. (USD)

EQUITY | Drug Manufacturers - General | Nasdaq Global Select

Last Closing

USD 89.94

Change

+0.06 (+0.07)%

Market Cap

USD 98.10B

Volume

6.52M

Analyst Target

USD 77.75
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-13 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZN AstraZeneca PLC ADR

-0.36 (-0.55%)

USD 202.63B
AMGN Amgen Inc

-3.09 (-1.14%)

USD 141.18B
SNY Sanofi ADR

-0.16 (-0.33%)

USD 124.51B
BIIB Biogen Inc

-7.12 (-4.74%)

USD 22.18B
GRFS Grifols SA ADR

-0.17 (-2.35%)

USD 7.13B
AMRN Amarin Corporation PLC

N/A

USD 0.18B
MIRA MIRA Pharmaceuticals, Inc. Com..

-0.02 (-1.68%)

USD 0.02B
SCLX Scilex Holding Company

+0.01 (+1.42%)

N/A
SCLXW Scilex Holding Company

N/A

N/A

ETFs Containing GILD

2B70:F iShares NASDAQ US Biotech.. 8.64 % 0.00 %

-0.12 (0.74%)

USD 0.52B
BTEC:SW 8.25 % 0.00 %

N/A

N/A
2B70:XETRA 8.22 % 0.00 %

N/A

N/A
IBBQ Invesco Nasdaq Biotechnol.. 8.22 % 0.00 %

-0.40 (0.74%)

USD 0.04B
UBIO 7.77 % 0.95 %

N/A

N/A
XDNA:CA iShares Genomics Immunolo.. 5.68 % 0.00 %

-1.12 (0.74%)

CAD 5.08M
FHI:CA CI Health Care Giants Cov.. 5.02 % 0.75 %

-0.07 (0.74%)

CAD 0.08B
TBG EA Series Trust 4.41 % 0.00 %

+0.10 (+0.74%)

USD 0.10B
UDI USCF ETF Trust 4.00 % 0.00 %

+0.26 (+0.74%)

N/A
JPHC:PA Amundi Index Solutions - .. 3.90 % 0.00 %

+0.60 (+0.74%)

USD 5.56M
JPHG:PA Amundi Index Solutions - .. 3.90 % 0.00 %

+1.58 (+0.74%)

N/A
JPHC:SW 3.90 % 0.00 %

N/A

N/A
JPHE:SW 3.90 % 0.00 %

N/A

N/A
JPHG:SW 3.90 % 0.00 %

N/A

N/A
JPHU:SW 3.90 % 0.00 %

N/A

N/A
JPNK:SW 3.90 % 0.00 %

N/A

N/A
JPNY:SW 3.90 % 0.00 %

N/A

N/A
QQQG Pacer Nasdaq 100 Top 50 C.. 3.66 % 0.00 %

+0.02 (+0.74%)

USD 2.11M
BAMD 3.63 % 0.00 %

N/A

N/A
CBUF:F 3.37 % 0.00 %

N/A

N/A
MDLV 3.19 % 0.00 %

N/A

N/A
WHCS:SW 3.19 % 0.00 %

N/A

N/A
QNXT iShares Nasdaq-100 ex Top.. 3.18 % 0.00 %

+0.18 (+0.74%)

USD 0.01B
MHOT:AU 2.94 % 0.00 %

N/A

N/A
MOAT:AU 2.93 % 0.00 %

N/A

N/A
WTD9:F 2.86 % 0.00 %

N/A

N/A
WTDY:F 2.86 % 0.00 %

N/A

N/A
WTEU:F 2.86 % 0.00 %

N/A

N/A
CURE:AU 2.80 % 0.00 %

N/A

N/A
MOTV:LSE VanEck Morningstar US Wid.. 2.73 % 0.00 %

N/A

USD 0.06B
MOTU:LSE VanEck Morningstar US Wid.. 2.73 % 0.00 %

+0.06 (+0.74%)

USD 0.06B
WMOT:XETRA 2.51 % 0.00 %

N/A

N/A
GOAT:AU 2.48 % 0.00 %

N/A

N/A
TDIV:SW 2.37 % 0.00 %

N/A

N/A
QUVU 2.20 % 0.00 %

N/A

N/A
HEAL:SW 2.08 % 0.00 %

N/A

N/A
2B78:XETRA 2.07 % 0.00 %

N/A

N/A
DHS:SW 2.04 % 0.00 %

N/A

N/A
DHSA:SW 2.04 % 0.00 %

N/A

N/A
SAGP The Advisorsa Inner Circl.. 2.01 % 0.00 %

+0.19 (+0.74%)

USD 0.04B
FLCV Federated Hermes ETF Trus.. 1.94 % 0.00 %

+0.30 (+0.74%)

USD 0.01B
RSPH Invesco S&P 500 Equal Wei.. 1.71 % 0.00 %

-0.18 (0.74%)

USD 0.83B
INCM:AU 1.66 % 0.00 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 1.64 % 0.00 %

-0.64 (0.74%)

CAD 0.01B
MVEW:LSE iShares Edge MSCI World M.. 1.45 % 0.00 %

+0.02 (+0.74%)

USD 0.30M
MVEC:SW 1.36 % 0.00 %

N/A

N/A
MVEW:SW 1.36 % 0.00 %

N/A

N/A
MVWE:SW 1.36 % 0.00 %

N/A

N/A
EVO:CA Evovest Global Equity ETF 0.96 % 0.00 %

+0.34 (+0.74%)

N/A
WELE:XETRA 0.59 % 0.00 %

N/A

N/A
FVD:LSE First Trust Value Line® .. 0.51 % 0.00 %

+0.19 (+0.74%)

USD 7.19M
UBBB:PA Amundi Index Solutions - .. 0.46 % 0.00 %

+0.18 (+0.74%)

USD 0.13B
BBH VanEck Biotech ETF 0.00 % 0.35 %

-2.88 (0.74%)

USD 0.40B
BBP Virtus LifeSci Biotech Pr.. 0.00 % 0.79 %

-1.15 (0.74%)

USD 0.02B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

-1.86 (0.74%)

USD 0.06B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

+0.66 (+0.74%)

USD 4.38M
BSCK 0.00 % 0.10 %

N/A

N/A
BSCL 0.00 % 0.10 %

N/A

N/A
BSCQ Invesco BulletShares 2026.. 0.00 % 0.10 %

N/A

N/A
CBND 0.00 % 0.16 %

N/A

N/A
DVP Roundhill Acquirers Deep .. 0.00 % 0.48 %

N/A

N/A
ESGW 0.00 % 0.40 %

N/A

N/A
FCY 0.00 % 0.84 %

N/A

N/A
FCY:CA 0.00 % 0.95 %

N/A

N/A
FDL First Trust Morningstar D.. 0.00 % 0.45 %

+0.28 (+0.74%)

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

-2.45 (0.74%)

USD 6.53B
IBCD 0.00 % 0.10 %

N/A

N/A
LABU Direxion Daily S&P Biotec.. 0.00 % 1.14 %

-7.17 (0.74%)

USD 0.82B
MOAT 0.00 % 0.49 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

+1.13 (+0.74%)

N/A
ONEY SPDR® Russell 1000® Yie.. 0.00 % 0.20 %

+1.01 (+0.74%)

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

-1.72 (0.74%)

N/A
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

-0.31 (0.74%)

USD 0.01B
IVFVC 0.00 % 0.00 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
JIGB 0.00 % 0.14 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
SPBO SPDR Portfolio Corporate .. 0.00 % 0.00 %

+0.02 (+0.74%)

USD 1.86B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.03 (+0.74%)

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.02 (+0.74%)

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.03 (+0.74%)

N/A
RJZ 0.00 % 0.75 %

N/A

N/A
SCIU 0.00 % 0.19 %

N/A

N/A
SDOG ALPS Sector Dividend Dogs.. 0.00 % 0.40 %

+0.35 (+0.74%)

USD 1.18B
SICK 0.00 % 0.95 %

N/A

N/A
SPYD SPDR® Portfolio S&P 500 .. 0.00 % 0.08 %

+0.39 (+0.74%)

USD 6.71B
WBIL WBI BullBear Quality 3000.. 0.00 % 1.07 %

+0.25 (+0.74%)

USD 0.04B
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

-2.47 (0.74%)

N/A
XMS:CA iShares Edge MSCI Min Vol.. 0.00 % 0.33 %

+0.12 (+0.74%)

N/A
ZBIO Zenas BioPharma, Inc. Com.. 0.00 % 0.95 %

-0.10 (0.74%)

N/A
ZLU:CA BMO Low Volatility US Equ.. 0.00 % 0.33 %

+0.14 (+0.74%)

CAD 1.91B
ZUH:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

-0.59 (0.74%)

CAD 0.23B
FCW:CA 0.00 % 0.90 %

N/A

N/A
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+7.20 (+0.74%)

N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.20 (+0.74%)

N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.15 (+0.74%)

N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+15.50 (+0.74%)

N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+9.25 (+0.74%)

N/A
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

-2.75 (0.74%)

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

-0.02 (0.74%)

N/A
MINV:LSE iShares VI Public Limited.. 0.00 % 0.00 %

+9.50 (+0.74%)

N/A
MVOL:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.32 (+0.74%)

N/A
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

-28.00 (0.74%)

N/A
JP40:F 0.00 % 0.00 %

N/A

N/A
JP4H:F 0.00 % 0.00 %

N/A

N/A
JP40:XETRA 0.00 % 0.00 %

N/A

N/A
JP4H:XETRA 0.00 % 0.00 %

N/A

N/A
VDIV:XETRA 0.00 % 0.00 %

N/A

N/A
WTD9:XETRA 0.00 % 0.00 %

N/A

N/A
WTDY:XETRA 0.00 % 0.00 %

N/A

N/A
WTEU:XETRA 0.00 % 0.00 %

N/A

N/A
TQGD:CA TD Q Global Dividend ETF 0.00 % 0.00 %

+0.03 (+0.74%)

CAD 0.19B
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
HDLB ETRACS Monthly Pay 2xLeve.. 0.00 % 0.00 %

+0.25 (+0.74%)

USD 8.16M
MVEW:XETRA 0.00 % 0.00 %

N/A

N/A
SCHJ Schwab 1-5 Year Corporate.. 0.00 % 0.00 %

+0.03 (+0.74%)

N/A
HDIV 0.00 % 0.00 %

N/A

N/A
SIXA 6 Meridian Mega Cap Equit.. 0.00 % 0.00 %

+0.30 (+0.74%)

USD 0.31B
SIXH ETC 6 Meridian Hedged Equ.. 0.00 % 0.00 %

+0.13 (+0.74%)

USD 0.48B
BMED BlackRock Future Health E.. 0.00 % 0.00 %

-0.20 (0.74%)

USD 3.01M
CBUF:XETRA 0.00 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

-0.15 (0.74%)

CAD 0.09B
2B78:F 0.00 % 0.00 %

N/A

N/A
GDOC Goldman Sachs ETF Trust 0.00 % 0.00 %

-0.53 (0.74%)

USD 0.02B
CSY9:XETRA 0.00 % 0.00 %

N/A

N/A
WDMVO:SW 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.63% 20% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.63% 20% F 40% F
Trailing 12 Months  
Capital Gain 4.12% 90% A- 57% F
Dividend Return 3.57% 75% C 59% D-
Total Return 7.69% 90% A- 59% D-
Trailing 5 Years  
Capital Gain 40.31% 100% F 72% C
Dividend Return 22.71% 100% F 82% B
Total Return 63.03% 100% F 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 0.76% 70% C- 41% F
Dividend Return 4.34% 70% C- 48% F
Total Return 3.58% 80% B- 74% C
Risk Return Profile  
Volatility (Standard Deviation) 24.87% 60% D- 70% C-
Risk Adjusted Return 17.44% 70% C- 49% F
Market Capitalization 98.10B 63% D 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers - General) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 7.00 14% 1%
Price/Book Ratio 5.72 25% 22%
Price / Cash Flow Ratio 14.30 75% 22%
Price/Free Cash Flow Ratio 33.72 13% 11%
Management Effectiveness  
Return on Equity 0.56% 38% 59%
Return on Invested Capital 18.78% 100% 86%
Return on Assets 11.96% 100% 96%
Debt to Equity Ratio 101.56% 50% 23%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector